Unlock instant, AI-driven research and patent intelligence for your innovation.

Nanovesicles derived from enhydrobacter bacteria, and use thereof

A technology of vesicles and water bacteria, which is applied in the fields of bacterial medical raw materials, applications, and functions of food ingredients, can solve the problems of unreported vesicle secretion, no diagnosis and treatment, etc.

Pending Publication Date: 2020-10-23
MD HEALTHCARE INC
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the fact that vesicles are secreted extracellularly from bacteria of the genus Aquaticum has not been reported, and there are no cases where bacteria of the genus Aquaticum are used for the diagnosis and treatment of intractable diseases such as cancer, cardiovascular disease, and diabetes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanovesicles derived from enhydrobacter bacteria, and use thereof
  • Nanovesicles derived from enhydrobacter bacteria, and use thereof
  • Nanovesicles derived from enhydrobacter bacteria, and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] Example 1. Analysis of In vivo Absorption, Distribution and Excretion Patterns of Gut Bacteria and Bacteria-Derived Vesicles

[0073] To assess whether gut bacteria and bacterial-derived vesicles are absorbed systemically through the gastrointestinal tract, the following experiments were performed. A dose of 50 μg of each of the fluorescently labeled enterobacteria and the vesicles derived from the enterobacteria was administered to the stomach of the mouse via the gastrointestinal tract, and at 0 minutes, 5 minutes, 3 hours, 6 hours and Fluorescence was measured after 12 hours. As a result of observing the whole image of the mouse, as Figure 1A As shown, bacteria were not taken up systemically, but vesicles derived from bacteria were absorbed systemically at 5 minutes after administration, and strong fluorescence was observed in the bladder at 3 hours after administration, making it possible to see that the vesicles were excreted. to the urinary tract. Furthermore...

Embodiment 2

[0075] Example 2. Metagenomic analysis of bacterial-derived vesicles in clinical samples

[0076] After first placing the blood sample into a 10 ml tube and allowing the suspension to settle by centrifugation (3,500 xg, 10 min, 4°C), only the supernatant was transferred to a new 10 ml tube. After removing bacteria and impurities using a 0.22-μm filter, transfer them to a Centriprep tube (centrifugal filter 50 kD) and centrifuge at 1,500 × g and 4 °C for 15 min, discard the material smaller than 50 kD, and The product was concentrated to 10ml. After bacteria and impurities were removed again using a 0.22-μm filter, supernatant was discarded and aggregated pellets were dissolved by performing ultracentrifugation at 150,000×g and 4°C for 3 hours using a 90Ti type rotor in normal saline (PBS).

[0077] 100 μl of vesicles isolated by the method described above were boiled at 100 °C to extract internal DNA from lipids, and then cooled on ice for 5 min. Then, in order to remove ...

Embodiment 3

[0081] Example 3. Metagenomic Analysis of Bacteria-Derived Vesicles in the Blood of Pancreatic Cancer Patients

[0082] Genes were extracted from the vesicles present in the blood of 176 pancreatic cancer patients and 271 normal individuals (both groups were matched in age and sex). The distribution of vesicles from bacteria of the genus Aquatobacter was assessed. As a result, it was confirmed that vesicles derived from bacteria of the genus Aquatus significantly decreased in blood from pancreatic cancer patients compared with blood from normal individuals (see Table 2 and Table 2). figure 2 ).

[0083] [Table 2]

[0084]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
absorbanceaaaaaaaaaa
Login to View More

Abstract

The present invention relates to vesicles derived from Enhydrobacter bacteria, and a use thereof. The present inventors experimentally confirmed that compared to those of a normal person, the vesiclesare significantly reduced in clinical samples from patients with pancreatic cancer, cholangiocarcinoma, breast cancer, ovarian cancer, lymphoma, myocardial infarction, cardiomyopathy, atrial fibrillation, variant angina, cirrhosis and diabetes; and when the vesicles isolated from a strain are administered, the secretion of inflammatory mediators by pathogenic vesicles, such as vesicles derived from Escherichia coli, is notably inhibited. Thus, the vesicles derived from Enhydrobacter bacteria, according to the present invention, may be usefully employed for the purpose of developing: a methodfor diagnosing pancreatic cancer, cholangiocarcinoma, breast cancer, ovarian cancer, lymphoma, myocardial infarction, cardiomyopathy, atrial fibrillation, variant angina, cirrhosis or diabetes; and acomposition for preventing, improving or treating said diseases.

Description

technical field [0001] The present invention relates to nanovesicles derived from bacteria of the genus Enhydrobacter and uses thereof, and more particularly, to the diagnosis of pancreatic cancer, cholangiocarcinoma, and breast cancer by using nanovesicles derived from bacteria of the genus Enhydrobacter , ovarian cancer, lymphoma, myocardial infarction, cardiomyopathy, atrial fibrillation, variant angina, liver cirrhosis or diabetes, and a composition comprising the vesicle for preventing, alleviating or treating the disease. Background technique [0002] Since the early 2000s, acute infectious diseases, which in the past were considered epidemics, have become less important, while chronic inflammatory diseases accompanied by immune dysfunction due to discord between humans and microbiomes have transformed disease pattern, becoming a major disease that determines the quality of life and human longevity. As intractable chronic diseases in the 21st century, cancer, cardiova...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/689C12Q1/6851A61K35/74A61P35/00A61P9/10A61P9/00A61P1/16A61P3/10A23L33/135
CPCY02A50/30A23L33/135A61K35/74A61P35/00A61P37/00C12Q1/689C12Q2600/158C12Q1/6851C12Q2600/112A23V2002/00A23V2200/308A61P9/10A61P3/10A61K2039/52C12Q1/6844
Inventor 金润根
Owner MD HEALTHCARE INC